7459 Stock Overview
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
MediPal Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,381.50 |
| 52 Week High | JP¥2,770.00 |
| 52 Week Low | JP¥2,170.50 |
| Beta | 0.12 |
| 1 Month Change | -2.99% |
| 3 Month Change | -6.04% |
| 1 Year Change | 4.82% |
| 3 Year Change | 10.31% |
| 5 Year Change | -2.16% |
| Change since IPO | 89.83% |
Recent News & Updates
MediPal Holdings (TSE:7459) Is Due To Pay A Dividend Of ¥30.00
Dec 19
MediPal Holdings (TSE:7459) Will Pay A Dividend Of ¥30.00
Dec 04We Think That There Are Issues Underlying MediPal Holdings' (TSE:7459) Earnings
Nov 27Recent updates
MediPal Holdings (TSE:7459) Is Due To Pay A Dividend Of ¥30.00
Dec 19MediPal Holdings (TSE:7459) Will Pay A Dividend Of ¥30.00
Dec 04We Think That There Are Issues Underlying MediPal Holdings' (TSE:7459) Earnings
Nov 27Returns On Capital At MediPal Holdings (TSE:7459) Have Stalled
Oct 14MediPal Holdings (TSE:7459) Will Pay A Dividend Of ¥30.00
Aug 28Calculating The Fair Value Of MediPal Holdings Corporation (TSE:7459)
Aug 24MediPal Holdings (TSE:7459) Has Announced A Dividend Of ¥30.00
Aug 06MediPal Holdings Corporation (TSE:7459) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 05Returns On Capital At MediPal Holdings (TSE:7459) Have Hit The Brakes
Jun 25Concerns Surrounding MediPal Holdings' (TSE:7459) Performance
May 22Some Confidence Is Lacking In MediPal Holdings Corporation's (TSE:7459) P/E
May 08Shareholder Returns
| 7459 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -2.1% | -2.0% | -1.5% |
| 1Y | 4.8% | -9.4% | 13.7% |
Return vs Industry: 7459 exceeded the JP Healthcare industry which returned -9.4% over the past year.
Return vs Market: 7459 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
| 7459 volatility | |
|---|---|
| 7459 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 7459 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7459's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1898 | 13,075 | Shuichi Watanabe | www.medipal.co.jp |
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.
MediPal Holdings Corporation Fundamentals Summary
| 7459 fundamental statistics | |
|---|---|
| Market cap | JP¥495.23b |
| Earnings (TTM) | JP¥46.05b |
| Revenue (TTM) | JP¥3.60t |
10.8x
P/E Ratio0.1x
P/S RatioIs 7459 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7459 income statement (TTM) | |
|---|---|
| Revenue | JP¥3.60t |
| Cost of Revenue | JP¥3.35t |
| Gross Profit | JP¥251.72b |
| Other Expenses | JP¥205.67b |
| Earnings | JP¥46.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 10, 2025
| Earnings per share (EPS) | 221.43 |
| Gross Margin | 6.98% |
| Net Profit Margin | 1.28% |
| Debt/Equity Ratio | 0% |
How did 7459 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield14%
Payout RatioDoes 7459 pay a reliable dividends?
See 7459 dividend history and benchmarks| MediPal Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 04 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 164 days |
Does 7459 pay a reliable dividends?
See 7459 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:49 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MediPal Holdings Corporation is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Global Markets Japan Inc. |